Tuesday, September 29, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· May 25, 2026

Stellora.AI Advances Quantum Flow to Support Healthcare, Drug Discovery, and Disease Research

View original at globenewswire.com
Stellora.AI Advances Quantum Flow to Support Healthcare, Drug Discovery, and Disease Research Prague, Czechia, May 25, 2026 (GLOBE NEWSWIRE) -- Stellora.AI, a deep-tech artificial intelligence startup developing advanced agentic AI and quantum workflow technology, today announced the continued advancement of Stellora.A…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stellora.AI is opening demo access because it wants serious partners to experience where the technology is going and how it can support meaningful scientific progress.

    60% confidence

  • Quantum Flow is not intended to replace researchers, doctors, or pharmaceutical laboratories, but is being developed as a powerful workflow assistant for scientific teams.

    60% confidence

  • Quantum Flow is designed to generate functional quantum circuits and quantum code tailored to specific research goals, working with scientific studies, quantum theories, target machine SDK documentation, and target quantum machine requirements.

    60% confidence

  • With Quantum Flow, Stellora.AI is building a bridge between validated research, quantum SDKs, and functional quantum circuits so researchers can move faster from idea to experimentation.

    60% confidence

  • Stellora.AI sees Quantum Flow as applicable for biomedical discovery, computational chemistry, precision medicine, and disease research where complex modeling and simulation are essential.

    60% confidence

  • Every improvement in Quantum Flow brings Stellora.AI closer to a future where AI can help scientists generate, test, and refine quantum workflows for healthcare, drug discovery, and disease research, with the goal of empowering researchers rather than replacing them.

    60% confidence

  • Stellora.AI was never created to be just another AI tool. Our mission is to help humanity by making advanced, trusted intelligence available for the most important scientific challenges.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
The Agentic Takeover of the CFO's Office
Enterprise finance software vendors—BlackLine, OneStream, Numero AI, and Oracle—are racing to embed autonomous AI agents into core financial operations (close, consolidation, reporting), backed by consolidation M&A (Numero-Royu, BlackLine-WiseLayer), fresh leadership hires, and survey data showing nearly a quarter of CFOs plan to boost AI spending over 50%. Adoption momentum is strong even as at least one bellwether (Oracle) sees its stock lag year-to-date, suggesting the market hasn't yet fully priced in the shift from AI-as-feature to AI-as-agent in finance.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Two significantly different EPS values (10.21 vs 2.68 USD_per_share) are reported for Morgan Stanley on the same observation date (2025-12-31). Fact A specifies FY 2025, while Fact B's 'N/A' fiscal period is ambiguous. If both represent FY 2025 annual EPS, these values directly conflict. The magnitude of the difference (3.8x) is too large to attribute to rounding or minor calculation variations. The missing fiscal period in Fact B raises data quality concerns, but same-date observation + same attribute should reference the same period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,314 source documents archived
Query this data → isubstrate.com